ÂÜÀòÂÒÂ×

Matthew Redinbo, PhD, Secretary, is a co-founder of Symberix and a Kenan Distinguished Professor at University of North Carolina at Chapel Hill in the Departments of Chemistry, Biochemistry & Biophysics, and Microbiology & Immunology. He was Chair of UNC’s Chemistry Department from 2009-2012. He has authored more than 100 publications based on original research and has been invited by the FDA to discuss the scientific and regulatory aspects of microbiome-targeted therapeutic interventions. Dr. Redinbo earned his BS in Biochemistry and English from University of California Davis and PhD in Biochemistry from University of California Los Angeles.